Abstract:This study reports on the dynamic changes in alternative splicing during the maternal‐to‐zygotic transition (MZT) and describes the previously unnoticed process of zygotic splicing activation (ZSA). Zygotic splicing activation depends on key maternal factors BTG4 and PABPN1L and is zygotic transcription‐dependent. Zygotic alternative splicing also regulates the conversion of early embryonic blastomeres from totipotency to pluripotency. During maternal‐to‐zygotic transition (MZT) in the embryo, mRNA undergoes complex post‐transcriptional regulatory processes. However, it is unclear whether and how alternative splicing plays a functional role in MZT. By analyzing transcriptome changes in mouse and human early embryos, dynamic changes in alternative splicing during MZT are observed and a previously unnoticed process of zygotic splicing activation (ZSA) following embryonic transcriptional activation is described. As the underlying mechanism of RNA splicing, splicing factors undergo dramatic maternal‐to‐zygotic conversion. This conversion relies on the key maternal factors BTG4 and PABPN1L and is zygotic‐transcription‐dependent. CDK11‐dependent phosphorylation of the key splicing factor, SF3B1, and its aggregation with SRSF2 in the subnuclear domains of 2‐cell embryos are prerequisites for ZSA. Isoforms generated by erroneous splicing, such as full‐length Dppa4, hinder normal embryonic development. Moreover, alternative splicing regulates the conversion of early embryonic blastomeres from totipotency to pluripotency, thereby affecting embryonic lineage differentiation. ZSA is an essential post‐transcriptional process of MZT and has physiological significance in generating new life. In addition to transcriptional activation, appropriate expression of transcript isoforms is also necessary for preimplantation embryonic development.

Maternal factor Trim75 contributes to zygotic genome activation program in mouse early embryos

Maternal KLF17 controls zygotic genome activation by acting as a messenger for RNA Pol II recruitment in mouse embryos

Maternal TDP-43 interacts with RNA Pol II and regulates zygotic genome activation

Maternal RNF114-mediated target substrate degradation regulates zygotic genome activation in mouse embryos

Maternal SMARCA5 is required for major ZGA in mouse embryos

Characterization of Zygotic Genome Activation-Dependent Maternal Mrna Clearance in Mouse

CBP/p300 and HDAC activities regulate H3K27 acetylation dynamics and zygotic genome activation in mouse preimplantation embryos

Maternal Factors Regulate Embryonic Development in Zebrafish

The histone deacetylase activity of HDAC1/2 is required to safeguard zygotic genome activation in mice and cattle

Kick-starting the zygotic genome: licensors, specifiers, and beyond

Maternal UHRF1 Is Essential for Transcription Landscapes and Repression of Repetitive Elements During the Maternal-to-Zygotic Transition

Methionine adenosyltransferase 2A regulates mouse zygotic genome activation and morula to blastocyst transition.

Zygotic Splicing Activation of the Transcriptome is a Crucial Aspect of Maternal‐to‐Zygotic Transition and Required for the Conversion from Totipotency to Pluripotency

Nanog, Pou5f1 and SoxB1 activate zygotic gene expression during the maternal-to-zygotic transition

Pivotal role for long noncoding RNAs in zygotic genome activation in mice

RNA‐Binding Protein IGF2BP2/IMP2 is a Critical Maternal Activator in Early Zygotic Genome Activation

The identification and classification of candidate genes during the zygotic genome activation in the mammals

Oocyte-expressed Yes-Associated Protein is a Key Activator of the Early Zygotic Genome in Mouse

OBOX Regulates Mouse Zygotic Genome Activation and Early Development

The Dynamics of Histone Modifications during Mammalian Zygotic Genome Activation

Minor zygotic gene activation is essential for mouse preimplantation development